Fredun Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 797.27 million compared to INR 694.47 million a year ago. Revenue was INR 798.04 million compared to INR 718.45 million a year ago. Net income was INR 38.92 million compared to INR 22.96 million a year ago. Basic earnings per share from continuing operations was INR 8.59 compared to INR 5.18 a year ago.
For the full year, sales was INR 2,743.42 million compared to INR 2,217.37 million a year ago. Revenue was INR 2,764.98 million compared to INR 2,260.89 million a year ago. Net income was INR 108.07 million compared to INR 63.35 million a year ago. Basic earnings per share from continuing operations was INR 22.93 compared to INR 14.29 a year ago.